These viruses are a royal pain in the backend…

Now, aside from the coronavirus, moneypox is apparently making the rounds.

“Doctors warned that numbers will rise significantly as the virus spreads through Europe and as far as the US, Canada and Australia. Spain now has the highest number of infections, outside places in Africa where the virus is endemic, with more than 50 known cases.”

Officials are even investigating a presumptive case in South Florida. Another case popped up in Massachusetts, and another in New York City. Worse, President Biden just said, “Everybody should be concerned. We’re working on it, hard to figure out what we do.” Even the World Health Organization just warned that Europe could see a wave of infections this summer.

The good news – According to the CDC, smallpox vaccines can protect people from the virus. “Past data from Africa suggests that the smallpox vaccine is at least 85% effective in preventing monkeypox,” says the agency.

So, how can we potentially profit from it?

Vaccine Stock No. 1 – Emergent Biosolutions (EBS)

Emergent Biosolutions produces the ACAM2000 vaccine, which the US FDA describes as an active immunization against smallpox for those at higher risk. “According to the Centers for Disease Control and Prevention, since the monkeypox virus is closely related to the virus that causes smallpox, ACAM2000 can be used to prevent the spread of monkeypox,” says Barron’s.